Ms. Sarina Lin, Vice Chairwoman and Deputy General Manager of Honeybear Biosciences, as well as a key driving force within Mercuries & Associates Holding, Ltd., brings 25 years of extensive multinational pharmaceutical experience back to the family-owned local enterprise. By combining the managerial expertise of global pharma with the people-centered values of a long-established local business group, she has been guiding Honeybear Biosciences steadily forward in R&D, international expansion, and corporate sustainability. This year, she led the team to be recognized as the 2025 Best ADC Developer in Taiwan and, as Taiwan’s first ARC R&D team, to win the Best Potential Award at NBRP Demo Day. Throughout her journey, she has extended her dedication into the highly specialized and high-risk field of biotechnology, encouraging the Honeybear Biosciences team to embrace openness, transparent communication, efficient collaboration, and to unleash their full potential while constantly pursuing innovation.
The biotech industry requires both advanced research and heavy investment, which has long posed challenges in Taiwan. How has VP Lin introduced management practices from multinational pharmaceutical companies? And how has her unique perspective as a woman enhanced her leadership style? In the program “Voices of This Generation”, through an engaging dialogue with the host, she not only shared her past experiences working in multinational companies but also highlighted critical structural challenges in today’s biotech industry: funding access and trust, value-chain integration, and the difficulties of connecting Taiwan with the global ecosystem. Honeybear Biosciences faces these very challenges as well, yet through its proprietary CoNectar® platform for ADC development, the company is poised to bring new hope to cancer patients. With careful and comprehensive evaluation of its own capabilities and technologies, the team aligned itself with the hottest trend in precision medicine—radiopharmaceuticals—choosing ARC as its first product, and notably, Taiwan’s first-ever ARC. VP Lin believes that in near future, many more exciting outcomes will emerge.
Honeybear Biosciences has also created a warm employee space called “Beehive”, inspired by the hive as a cradle of growth and transformation, symbolizing continuous progress and shared prosperity. The company promotes a culture of sharing and mutual growth, while also encouraging employee stock options and setting standards that foster inclusiveness. With her balanced leadership—firm yet empathetic—Sarina brings to Honeybear Biosciences a distinctive atmosphere and management style unlike the typical male-dominated corporate culture. Staying true to her principles of sincerity, sustainability, and legacy, she upholds a belief in openness and selflessness, paired with a life attitude of always striving to be her best. This spirit deeply influences the team, keeping the company moving forward with stability and strength.
~ Butterflies are enchanted by blossoms spontaneously; God helps those who help themselves. ~ Sarina Lin
The biotech industry requires both advanced research and heavy investment, which has long posed challenges in Taiwan. How has VP Lin introduced management practices from multinational pharmaceutical companies? And how has her unique perspective as a woman enhanced her leadership style? In the program “Voices of This Generation”, through an engaging dialogue with the host, she not only shared her past experiences working in multinational companies but also highlighted critical structural challenges in today’s biotech industry: funding access and trust, value-chain integration, and the difficulties of connecting Taiwan with the global ecosystem. Honeybear Biosciences faces these very challenges as well, yet through its proprietary CoNectar® platform for ADC development, the company is poised to bring new hope to cancer patients. With careful and comprehensive evaluation of its own capabilities and technologies, the team aligned itself with the hottest trend in precision medicine—radiopharmaceuticals—choosing ARC as its first product, and notably, Taiwan’s first-ever ARC. VP Lin believes that in near future, many more exciting outcomes will emerge.
Honeybear Biosciences has also created a warm employee space called “Beehive”, inspired by the hive as a cradle of growth and transformation, symbolizing continuous progress and shared prosperity. The company promotes a culture of sharing and mutual growth, while also encouraging employee stock options and setting standards that foster inclusiveness. With her balanced leadership—firm yet empathetic—Sarina brings to Honeybear Biosciences a distinctive atmosphere and management style unlike the typical male-dominated corporate culture. Staying true to her principles of sincerity, sustainability, and legacy, she upholds a belief in openness and selflessness, paired with a life attitude of always striving to be her best. This spirit deeply influences the team, keeping the company moving forward with stability and strength.
~ Butterflies are enchanted by blossoms spontaneously; God helps those who help themselves. ~ Sarina Lin
Honeybear Biosciences Vice Chairwoman and Deputy General Manager Sarina Lin Invited for a Special Interview on “Voices of This Generation”
